Mikael Dolsten
Chief Scientific Officer & President, WW Research, Development & Medical
Mikael Dolsten focuses on advancing Pfizer’s scientific breakthrough leadership in small-molecule medicines, biotherapeutics, gene therapies and vaccines. He is a member of the Executive Leadership Team and the company’s Portfolio Strategy and Investment Committee, which governs major pipeline investments and strategic end-to-end R&D priorities....
Roles at Pfizer
Chief Scientific Officer & President, WW Research, Development & Medical
Current role
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at Pfizer
My pet peeves
My communication style
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.